• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $NIVF

    NewGenIvf Group Limited

    Subscribe to $NIVF
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    IPO Year:

    Exchange: NASDAQ

    Recent Analyst Ratings for NewGenIvf Group Limited

    DatePrice TargetRatingAnalyst
    See more ratings

    NewGenIvf Group Limited Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Hrt Financial Lp bought $32,000 worth of shares (34,756 units at $0.92), increasing direct ownership by 72% to 83,079 units (SEC Form 4)

    4 - NewGenIvf Group Ltd (0001981662) (Issuer)

    6/4/26 4:08:25 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    New insider Hrt Financial Lp claimed ownership of 71,341 shares (SEC Form 3)

    3 - NewGenIvf Group Ltd (0001981662) (Issuer)

    6/4/26 4:02:22 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    Large owner Hrt Financial Lp sold $68,254 worth of shares (85,317 units at $0.80), decreasing direct ownership by 61% to 54,561 units (SEC Form 4)

    4 - NewGenIvf Group Ltd (0001981662) (Issuer)

    5/28/26 12:36:22 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    Large owner Hrt Financial Lp bought $161,919 worth of shares (165,534 units at $0.98) (SEC Form 4)

    4 - NewGenIvf Group Ltd (0001981662) (Issuer)

    5/27/26 1:19:20 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    New insider Hrt Financial Lp claimed ownership of 111,885 shares (SEC Form 3)

    3 - NewGenIvf Group Ltd (0001981662) (Issuer)

    5/27/26 1:11:24 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 4 filed by Chief Marketing Officer Fong Hei Yue Tina

    4 - NewGenIvf Group Ltd (0001981662) (Issuer)

    5/6/26 4:01:14 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 4 filed by Chairman & CEO Siu Wing Fung Alfred

    4 - NewGenIvf Group Ltd (0001981662) (Issuer)

    5/6/26 4:01:16 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 3 filed by new insider Siu Wing Fung Alfred

    3 - NewGenIvf Group Ltd (0001981662) (Issuer)

    3/31/26 6:35:06 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 3 filed by new insider Fong Hei Yue Tina

    3 - NewGenIvf Group Ltd (0001981662) (Issuer)

    3/27/26 6:31:07 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 3 filed by new insider Ching Chan Florianna Ann Chi Wan

    3 - NewGenIvf Group Ltd (0001981662) (Issuer)

    3/27/26 6:29:39 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    NewGenIvf Group Limited SEC Filings

    View All

    SEC Form 6-K filed by NewGenIvf Group Limited

    6-K - NewGenIvf Group Ltd (0001981662) (Filer)

    6/4/26 8:30:11 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 6-K filed by NewGenIvf Group Limited

    6-K - NewGenIvf Group Ltd (0001981662) (Filer)

    5/28/26 8:49:43 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 6-K filed by NewGenIvf Group Limited

    6-K - NewGenIvf Group Ltd (0001981662) (Filer)

    5/21/26 8:31:37 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    SEC Form RW filed by NewGenIvf Group Limited

    RW - NewGenIvf Group Ltd (0001981662) (Filer)

    5/12/26 4:01:15 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 20-F filed by NewGenIvf Group Limited

    20-F - NewGenIvf Group Ltd (0001981662) (Filer)

    3/31/26 5:29:44 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    SEC Form EFFECT filed by NewGenIvf Group Limited

    EFFECT - NewGenIvf Group Ltd (0001981662) (Filer)

    3/16/26 12:15:12 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 424B3 filed by NewGenIvf Group Limited

    424B3 - NewGenIvf Group Ltd (0001981662) (Filer)

    3/13/26 8:01:02 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 6-K filed by NewGenIvf Group Limited

    6-K - NewGenIvf Group Ltd (0001981662) (Filer)

    3/11/26 8:03:08 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    SEC Form F-1 filed by NewGenIvf Group Limited

    F-1 - NewGenIvf Group Ltd (0001981662) (Filer)

    3/2/26 5:30:55 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 6-K filed by NewGenIvf Group Limited

    6-K - NewGenIvf Group Ltd (0001981662) (Filer)

    1/20/26 8:07:33 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    NewGenIvf Group Limited Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Hrt Financial Lp bought $32,000 worth of shares (34,756 units at $0.92), increasing direct ownership by 72% to 83,079 units (SEC Form 4)

    4 - NewGenIvf Group Ltd (0001981662) (Issuer)

    6/4/26 4:08:25 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    Large owner Hrt Financial Lp bought $161,919 worth of shares (165,534 units at $0.98) (SEC Form 4)

    4 - NewGenIvf Group Ltd (0001981662) (Issuer)

    5/27/26 1:19:20 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    NewGenIvf Group Limited Press Releases

    Fastest customizable press release news feed in the world

    View All

    K25.ai Secures US$6 Million Strategic Investment from Nasdaq-Listed NewGen at US$100 Million Valuation; Co-Founders to Join Board and Lead Digital Asset Treasury Strategy

    SINGAPORE, June 4, 2026 /PRNewswire/ -- K25.ai, an AI-native livestreaming and watch-to-predict prediction market platform purpose-built for Asia-Pacific, today announced that NewGenIVF Group Limited (NASDAQ:NIVF) ("NewGen") has committed an additional US$4 million strategic investment in K25.ai, bringing NewGen's total strategic investment in K25.ai to US$6 million at an implied valuation of US$100 million and further deepening the partnership between the two companies. The additional investment strengthens NewGen's strategic exposure to K25.ai and underscores growing recognition of K25.ai's positioning at the convergence of AI, livestreaming, digital assets and prediction markets. As part

    6/4/26 9:00:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    NewGen Doubles Down on K25.ai with Additional US$4 Million Stake and Adopts Digital Asset Treasury Strategy

    NewGen's 6% Stake in K25.ai Now Valued at US$6 MillionCompany will Leverage Expertise of K25.ai's Andy Cheung to Develop Digital Asset Treasury Strategy BANGKOK, June 04, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today announced it has exercised its top-up option to acquire an additional 4% equity interest in AI-native livestreaming prediction market platform K25.ai, raising its total holding to 6%. The additional US$4 million investment, which supplements an initial US$2 million investment announced in May 2026, is split evenly between cash and newly issued NewGen Class A ordinary shares.

    6/4/26 8:30:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    NewGen Executes Share Purchase Agreement and Obtains Exclusive APAC Agency Rights with K25.ai, an AI-Powered Prediction Market Led by Industry Veteran Andy Cheung

    NewGen executes Share Purchase Agreement to acquire an initial 2% equity interest in K25.ai, with the right to invest up to 10% in totalNewGen also executes Exclusive Agency Agreement with K25.ai, appointing NewGen as K25.ai's exclusive agency partner for selected permitted APAC markets, creating a potential asset-light commercial growth channelAccording to media reports citing Bernstein research, prediction market volumes could reach approximately US$1 trillion by 2030 as the category evolves into broader information markets across sports, crypto, politics, macroeconomic and event-driven contractsAPAC market tailwinds across mobile, digital economy, gaming, esports, live-streaming, social v

    5/28/26 8:30:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    K25.ai, Led by Tech Veteran Andy Cheung, Eyes Public Listing as World's First Prediction Market After $100M Valuation Investment from Nasdaq-Listed Strategic Partner

    Nasdaq-listed NIVF has made an initial US$2 million strategic investment in K25.ai (with an option for up to US$10M). K25.ai co-founders will join NIVF's board to support deeper strategic alignment, as the partnership accelerates K25.ai's AI-native watch-to-predict platform and APAC expansion. K25.ai is also pursuing a potential public-market pathway, including through a strategic transaction or RTO.SINGAPORE, May 21, 2026 /PRNewswire/ -- K25.ai, an APAC-focused AI-native live streaming and watch-to-predict platform, today announced the closing of a US$100 million-valued Pre-A strategic investment round led by NewGenIVF Group Limited (NASDAQ:NIVF) ("NewGenIVF" or "NIVF"), together with an ex

    5/21/26 9:00:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    NewGenIVF Announces Strategic Investment Agreement with Tech Veteran Andy Cheung-Led K25.ai, an AI-Powered Live-Streaming Prediction Market, at US$100 Million Valuation

    BANGKOK and SINGAPORE, May 21, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (NASDAQ:NIVF) ("NewGenIVF" or the "Company"), a technology-driven, diversified growth company, today announced that it has entered into a strategic investment agreement with K25.ai, an APAC-focused AI-powered watch-to-predict platform led by Mr. Andy Cheung, former Chief Operating Officer of OKX and former Chief Executive Officer of Groupon Hong Kong. K25.ai is designed to combine artificial intelligence, live-streaming content, creator communities and prediction-based engagement into a watch-to-predict consumer platform for permitted APAC markets. The strategic relationship is intended to provide NewGenIVF wi

    5/21/26 8:30:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    NewGen Provides Update on Fiscal Year 2025 Results and Strategic Progress

    NewGen records strong balance sheet with total assets of US$32.7 million Net profit attributable to shareholders of the Company of US$9.9 million BANGKOK, May 04, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group (NASDAQ:NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today outlined several highlights of its fiscal year 2025 results and the steady progress of its continued strategic transformation. More information on NewGen's results can be found in the Company's annual report on Form 20-F for the fiscal year ended December 31, 2025, (the "2025 Annual Report") which was filed with the U.S. Securities and Exchange Commission (the "SEC") in April 2026. The ful

    5/4/26 8:30:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    NewGen Filed 2025 Annual Report on Form 20-F

    BANGKOK, April 01, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2025, with the U.S. Securities and Exchange Commission (the "SEC"). The annual report can be accessed on the Company's investor relations website at https://investors.newgenivf.com. About NewGenIVF Group LimitedNewGenIVF Group is a tech-forward, diversified, multi-jurisdictional high-growth entity capitalizing on emerging opportunities across real estate development, digital asset innovation and reproductive health solutions. Th

    4/1/26 7:00:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    NewGen Signs MOU with Women in Web3 Hong Kong to Launch Regional Women's Health Awareness Initiative

    BANGKOK, March 02, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group (NASDAQ:NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today announced that it has entered into a Memorandum of Understanding ("MOU") with Women in Web3 Hong Kong Limited ("WiW3"), a leading community organization dedicated to advancing women and their allies in Hong Kong's Web3 ecosystem. Under the MOU, NewGen and WiW3 intend to collaborate on a co-branded public awareness and education campaign anchored by the NewGen manifesto and petition, with a primary focus on women's health literacy. The campaign will spotlight themes such as the urgency of improved education on women's health, the impa

    3/2/26 8:30:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    NewGen Provides Recap of Strategic Progress as Diversification Fuels Success, Positions Company for Breakout Year

    BANGKOK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group (NASDAQ:NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today outlined its remarkable financial and operational transformation, positioning the Company for significant value creation in 2026 and beyond. Over the past year, NewGen has successfully executed an extensive strategic pivot, building a robust balance sheet and a dynamic portfolio of high-growth international ventures. NewGen has completed a decisive corporate transformation, strengthening its foundation for accelerated growth. Through a proactive capital management strategy and strategic asset deployment, the Company has dramatically i

    2/24/26 8:30:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    NewGen and Evident Capital Successfully Activate Commitment Campaign for Inaugural Tokenized Real Estate Bond, Delivering on Cross-Border Real World Asset Financing Strategy

    Rapid progress from announcement of successful launch in under two weeks signals NewGen's expertise and commitment Launch represents fulfilment of NewGen's goals to spearhead Real World Asset tokenization, puts Company at the forefront of digital assets innovation BANGKOK, Feb. 04, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a tech-forward, diversified, multi-jurisdictional entity transforming industries through innovative solutions across real estate development, digital asset management and reproductive health solutions, is pleased to announce that the Commitment Campaign for its inaugural tokenized bond issuance is now live on Evident Ca

    2/4/26 8:30:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    NewGenIvf Group Limited Leadership Updates

    Live Leadership Updates

    View All

    NewGen Doubles Down on K25.ai with Additional US$4 Million Stake and Adopts Digital Asset Treasury Strategy

    NewGen's 6% Stake in K25.ai Now Valued at US$6 MillionCompany will Leverage Expertise of K25.ai's Andy Cheung to Develop Digital Asset Treasury Strategy BANGKOK, June 04, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today announced it has exercised its top-up option to acquire an additional 4% equity interest in AI-native livestreaming prediction market platform K25.ai, raising its total holding to 6%. The additional US$4 million investment, which supplements an initial US$2 million investment announced in May 2026, is split evenly between cash and newly issued NewGen Class A ordinary shares.

    6/4/26 8:30:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    NIVF Appoints Award-Winning Web3 Leader Joshua Chu to Spearhead Tokenization Strategy and Formally Engages Evident Capital to Launch Up to USD 30 Million in Tokenized Bonds by Q1, Outlining 2026 Value Catalysts

    BANGKOK, Jan. 21, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (("NewGen" or the "Company, NASDAQ:NIVF), a technology-driven company building a diversified ecosystem across fertility technology, digital assets, and real estate development, today announced the appointment of award-winning Web3 legal and regulatory specialist Joshua Chu as Senior Counsel to lead the Group's tokenization strategy, alongside the formal engagement of Evident Capital, Hong Kong's first fully integrated, SFC-licensed tokenization and alternative assets platform, to support the launch of NIVF's inaugural tokenized bond issuance of up to USD 30 million targeted for completion by the first quarter of 2026. As S

    1/21/26 8:30:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    NewGenDigital Appointed as SAXA Inc.'s Agent for Tokenization of US$100 Million of Gold-backed Assets

    Service agreement with SAXA, Inc. appoints NewGenDigital as SAXA's worldwide tokenization agent, strengthening cooperation between the two companies ahead of proposed reverse merger Value of tokenized assets could be expanded to US$1 billion under the terms of the agreement; NewGenDigital to earn 5% commission on assets sold BANGKOK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a tech-forward, diversified, multi-jurisdictional high-growth entity transforming industries through innovative solutions across real estate development, digital asset management and reproductive health solutions, today announced that its subsidiary, NewGenD

    11/5/25 9:00:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director

    Company Granted Request to Continue its Listing on NasdaqAppoints Thorain Ko to Lead Business Development Initiatives BANGKOK, Feb. 20, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that the Nasdaq Hearings Panel (the "Panel") has granted the Company's request for continued listing on The Nasdaq Stock Market, subject to specific conditions. Additionally, the Company announced the appointment of Mr. Thorain Ko as Business Development Director to drive its expansion initiatives. Nasdaq Listing UpdateThe Pane

    2/20/25 6:00:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    NewGenIvf Group Limited Financials

    Live finance-specific insights

    View All

    NewGen Provides Update on Fiscal Year 2025 Results and Strategic Progress

    NewGen records strong balance sheet with total assets of US$32.7 million Net profit attributable to shareholders of the Company of US$9.9 million BANGKOK, May 04, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group (NASDAQ:NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today outlined several highlights of its fiscal year 2025 results and the steady progress of its continued strategic transformation. More information on NewGen's results can be found in the Company's annual report on Form 20-F for the fiscal year ended December 31, 2025, (the "2025 Annual Report") which was filed with the U.S. Securities and Exchange Commission (the "SEC") in April 2026. The ful

    5/4/26 8:30:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    NewGenIvf Group Limited Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by NewGenIvf Group Limited

    SC 13G - NewGenIvf Group Ltd (0001981662) (Subject)

    12/5/24 8:23:57 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13G filed by NewGenIvf Group Limited

    SC 13G - NewGenIvf Group Ltd (0001981662) (Subject)

    11/13/24 9:19:27 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13G filed by NewGenIvf Group Limited

    SC 13G - NewGenIvf Group Ltd (0001981662) (Subject)

    10/10/24 3:39:26 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care